搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
tcrx
/
财务摘要
TScan Therapeutics Inc
TCRX
添加自选
0.355
USD
+0.024
+7.25%
收盘 09-22 16:00(美东)
23.72M
总市值
亏损
市盈率 TTM
盘后交易 18:05 (美东)
0.359
USD
+0.007
+1.99%
TScan Therapeutics Inc
0.355
+0.024
+7.25%
概览
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
TCRX 财务数据
通过专为投资者打造的一站式数据看板,全面查看 TScan Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
23.72M
股息TTM
0.00
市盈率 TTM
-0.37
每股收益TTM
-0.96
营业收入
10.32M
净利润
-127.50M
净资产收益率
-80.95%
总资产收益率
-46.50%
TScan Therapeutics Inc 财报日历
最新发布
8月 12, 2026
每股收益 / 预测值
-0.23
/-0.21
营业收入 / 预测值
1.05M
/1.67M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
17.98%
-0.23
16.16%
-0.22
40.29%
-0.18
-9.23%
-0.28
-2.04%
-0.28
17.16%
-0.26
-43.92%
-0.30
-3.83%
-0.25
45.19%
-0.28
65.89%
-0.32
73.52%
-0.21
--
-0.24
--
-0.51
--
-0.93
--
-0.78
--
-1.98
--
--
--
--
--
--
--
--
营业收入
-65.83%
1.05M
-54.77%
982.00K
286.02%
2.57M
139.37%
2.51M
473.88%
3.08M
283.57%
2.17M
-90.78%
665.00K
-73.01%
1.05M
-82.97%
536.00K
-91.68%
566.00K
132.99%
7.21M
15.58%
3.89M
-22.39%
3.15M
125.19%
6.80M
8.44%
3.10M
39.43%
3.36M
42.42%
4.06M
49.04%
3.02M
258.99%
2.85M
731.72%
2.41M
净利润
17.84%
-30.36M
16.00%
-28.67M
35.83%
-22.98M
-19.48%
-35.71M
-16.71%
-36.95M
-13.22%
-34.13M
-82.58%
-35.81M
-29.96%
-29.89M
-31.67%
-31.66M
-33.59%
-30.14M
-4.75%
-19.61M
-41.56%
-23.00M
-59.27%
-24.05M
-39.66%
-22.56M
-31.85%
-18.72M
-2.56%
-16.25M
-41.44%
-15.10M
-104.20%
-16.16M
-81.89%
-14.20M
-120.91%
-15.84M
利润率
-140.45%
-2888.58%
-85.70%
-2919.14%
83.38%
-895.09%
50.08%
-1422.14%
79.66%
-1201.30%
70.48%
-1571.95%
-1879.80%
-5384.81%
-381.56%
-2849.09%
-673.34%
-5906.90%
-1505.68%
-5325.44%
55.04%
-271.99%
--
-591.64%
--
-763.82%
--
-331.66%
--
-604.94%
--
-454.96%
--
--
--
--
--
--
--
--
毛利率
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
--
100.00%
--
100.00%
--
100.00%
--
100.00%
--
100.00%
--
--
--
--
--
--
--
--
资产负债率
76.74%
19.12%
67.13%
16.17%
64.55%
14.22%
40.37%
12.36%
33.18%
10.82%
-22.98%
9.67%
-21.73%
8.64%
-14.31%
8.81%
-13.39%
8.12%
-26.11%
12.56%
-24.95%
11.04%
--
10.28%
--
9.38%
--
17.00%
--
14.71%
--
17.57%
--
--
--
--
--
--
--
--
利润表
营业收入
-65.83%
1.05M
-54.77%
982.00K
286.02%
2.57M
139.37%
2.51M
473.88%
3.08M
283.57%
2.17M
-90.78%
665.00K
-73.01%
1.05M
-82.97%
536.00K
-91.68%
566.00K
132.99%
7.21M
15.58%
3.89M
-22.39%
3.15M
125.19%
6.80M
8.44%
3.10M
39.43%
3.36M
42.42%
4.06M
49.04%
3.02M
258.99%
2.85M
731.72%
2.41M
营业利润
21.11%
-30.49M
19.62%
-29.14M
40.46%
-21.86M
-13.58%
-37.05M
-13.31%
-38.65M
-15.55%
-36.25M
-71.90%
-36.71M
-31.82%
-32.62M
-38.62%
-34.11M
-37.95%
-31.37M
-14.52%
-21.36M
-49.28%
-24.75M
-61.42%
-24.61M
-40.71%
-22.74M
-31.31%
-18.65M
-4.65%
-16.58M
-42.77%
-15.25M
-104.13%
-16.16M
-81.84%
-14.20M
-120.92%
-15.84M
净利润
17.84%
-30.36M
16.00%
-28.67M
35.83%
-22.98M
-19.48%
-35.71M
-16.71%
-36.95M
-13.22%
-34.13M
-82.58%
-35.81M
-29.96%
-29.89M
-31.67%
-31.66M
-33.59%
-30.14M
-4.75%
-19.61M
-41.56%
-23.00M
-59.27%
-24.05M
-39.66%
-22.56M
-31.85%
-18.72M
-2.56%
-16.25M
-41.44%
-15.10M
-104.20%
-16.16M
-81.89%
-14.20M
-120.91%
-15.84M
资产负债表
流动资产
-52.79%
104.40M
-47.90%
132.77M
-46.29%
157.21M
-31.35%
188.16M
-26.17%
221.13M
54.71%
254.84M
50.70%
292.72M
25.98%
274.08M
23.66%
299.53M
63.24%
164.72M
56.48%
194.24M
54.11%
217.57M
87.24%
242.22M
-30.77%
100.91M
-25.07%
124.13M
-24.51%
141.18M
17.53%
129.36M
17.66%
145.75M
--
165.65M
--
187.00M
流动负债总额
-1.14%
30.96M
-33.02%
19.97M
-48.01%
18.70M
1.91%
29.21M
-18.80%
31.32M
-5.28%
29.82M
20.58%
35.96M
-13.55%
28.66M
9.84%
38.57M
124.10%
31.48M
72.32%
29.82M
99.78%
33.15M
104.53%
35.12M
-23.93%
14.05M
-18.92%
17.30M
-27.68%
16.59M
-16.72%
17.17M
-1.98%
18.46M
--
21.34M
--
22.94M
总资产
-42.57%
171.45M
-39.29%
201.99M
-38.35%
228.79M
-24.65%
262.23M
-20.36%
298.56M
38.15%
332.71M
36.37%
371.12M
19.44%
348.03M
18.28%
374.87M
38.75%
240.83M
36.70%
272.15M
76.11%
291.38M
107.93%
316.92M
3.19%
173.58M
5.84%
199.09M
-19.25%
165.45M
17.24%
152.41M
19.34%
168.20M
--
188.11M
--
204.89M
总负债
-15.93%
102.43M
-14.23%
105.07M
-18.81%
105.67M
-0.62%
118.20M
1.84%
121.85M
3.94%
122.51M
7.31%
130.15M
-2.84%
118.94M
-5.28%
119.65M
23.34%
117.86M
21.70%
121.28M
150.88%
122.42M
508.37%
126.32M
324.52%
95.56M
264.66%
99.66M
58.35%
48.80M
-32.20%
20.76M
-28.43%
22.51M
--
27.33M
--
30.82M
总权益
-60.94%
69.02M
-53.89%
96.92M
-48.91%
123.12M
-37.13%
144.02M
-30.76%
176.71M
70.94%
210.20M
59.72%
240.97M
35.59%
229.09M
33.90%
255.22M
57.61%
122.97M
51.73%
150.87M
44.83%
168.96M
44.78%
190.61M
-46.45%
78.02M
-38.15%
99.43M
-32.98%
116.66M
32.47%
131.65M
33.07%
145.69M
--
160.78M
--
174.07M
现金流量表
经营净额
17.23%
-27.54M
35.40%
-24.28M
-16.74%
-32.00M
-16.28%
-32.46M
-26.85%
-33.27M
-28.42%
-37.59M
-15.34%
-27.41M
-448.24%
-27.92M
-19.09%
-26.23M
-24.08%
-29.27M
-48.44%
-23.77M
147.15%
8.02M
-64.75%
-22.02M
-17.21%
-23.59M
-11.34%
-16.01M
-24.65%
-17.00M
-24.93%
-13.37M
-102.11%
-20.12M
-95.65%
-14.38M
-135.62%
-13.64M
投资净额
-100.96%
-465.00K
-100.52%
-70.00K
-45.67%
14.83M
139.56%
32.58M
243.66%
48.44M
-62.59%
13.53M
1326.71%
27.29M
-34.09%
-82.35M
-7927.62%
-33.72M
4415.39%
36.16M
238.93%
1.91M
-14384.43%
-61.41M
77.81%
-420.00K
-57.82%
-838.00K
37.72%
-1.38M
50.29%
-424.00K
51.68%
-1.89M
82.05%
-531.00K
-59.64%
-2.21M
36.49%
-853.00K
融资净额
-14.66%
99.00K
100.00%
0.00
-99.84%
73.00K
-100.00%
0.00
-99.93%
116.00K
-303.49%
-525.00K
240373.68%
45.69M
588.10%
1.23M
19.10%
161.59M
--
258.00K
-82.41%
19.00K
-100.87%
-252.00K
437564.52%
135.68M
-100.00%
0.00
-10.00%
108.00K
-67.85%
29.13M
104.52%
31.00K
-99.91%
88.00K
200.00%
120.00K
9060700.00%
90.61M
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
TScan Therapeutics Inc的总收入是多少?
根据TScan Therapeutics Inc的FY2025财报,总收入达到了10.32M(同比变化2.82M)。
TScan Therapeutics Inc的流动资产是多少?
根据TScan Therapeutics Inc的FY2025财报,流动资产为157.21M(同比变化-46.29)。
TScan Therapeutics Inc的总资产是多少?
根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的总资产为228.79M(同比变化-38.35)。
TScan Therapeutics Inc的总负债是多少?
根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的总负债为105.67M(同比变化-18.81)。
TScan Therapeutics Inc的总权益是多少?
根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的总权益为123.12M(同比变化-48.91)。
TScan Therapeutics Inc的净营业收入是多少?
根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的净营业收入为-133.81M(同比变化0.75)。
TScan Therapeutics Inc的净投资是多少?
根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的净投资为109.37M(同比变化307.88)。
TScan Therapeutics Inc的净融资是多少?
根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的净融资为-336.00K(同比变化-100.16)。
TScan Therapeutics Inc的每股收益(EPS)是多少?
根据TScan Therapeutics Inc的FY2025财报,每股收益(EPS)为-1.00(同比变化12.17)。
TScan Therapeutics Inc的净利润是多少?
根据TScan Therapeutics Inc的FY2025财报,净利润为-129.77M(同比变化-1.78)。
TScan Therapeutics Inc的净利润率是多少?
根据TScan Therapeutics Inc的FY2025财报,净利润率为-1256.81(同比变化72.24)。
TScan Therapeutics Inc的债务与资产比率是多少?
根据TScan Therapeutics Inc的FY2025财报,债务与资产比率为14.22(同比变化64.55)。
TScan Therapeutics Inc的股东权益回报率(ROE)是多少?
根据TScan Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-71.28(同比变化-9.53)。
TScan Therapeutics Inc的资产回报率(ROA)是多少?
根据TScan Therapeutics Inc的FY2025财报,资产回报率(ROA)为-43.26(同比变化-9.13)。
TScan Therapeutics Inc的营业利润是多少?
根据TScan Therapeutics Inc的FY2025财报,营业利润为-133.81M(同比变化0.75)。